Top Penny Stocks List Weekly Update: April 26, 2021

Penny stocks can move fast and be highly volatile. To be successful, you need to make a list of stocks to watch — and potentially trade — every day. And remember, the market has shifted…

So keep studying and doing research. You don’t have to trade on any given day. Focus on the process and keep making a daily watchlist.

How do you choose stocks for your watchlist? It all starts with looking for big percent gainers. Keep reading for more about how to create your own penny stock watchlist.


trading penny stocks

News Moving the Penny Stocks on This List

It’s a busy week for corporate earnings reports. Roughly 84% of reporting S&P 500 companies have posted positive Q1 results. Watch penny stocks for sympathy plays on any big earnings winners.

Also, the recently announced proposal to hike capital gains tax has a lot of newbies up in arms. The reality is, it doesn’t change tax rates much for high-earning day traders…

Forget about what you can’t control. Instead, focus on what you can control — your commitment and dedication.

Read More

Read these related posts to learn more…

watchlist banner

Top Penny Stocks List Weekly Update: April 26, 2021

This week’s OTC watchlist includes designer bong-water, psychedelic medicine, and Picasso as a digital dividend…

Top OTCMarkets Penny Stocks To Watch

Below is my OTC penny stocks list for the week starting April 26, 2021. From psychedelic medicine to uplisting news, there’s a variety of catalysts. Be sure to read everything so you understand the thought process that goes into my list.

Top Penny Stocks List Weekly Update #1: Priority Aviation Inc. (OTCPK: PJET)

Priority Aviation supposedly arranges on-demand private jet charters. Like so many penny stock companies, a little digging shows something different…

The company is now “working to develop the business model acquired from Telluride Health Company – designer bong waters.” But the company still operates a charter jet themed website. What does the company do, exactly? I don’t know. Frankly, I don’t care.

PJET spiked on Friday after the company submitted annual reports for 2019 and 2020. The reports show zero revenue, but the market reacted positively anyway. You gotta love penny stocks.

See the 2020 annual report here and the 2019 annual report here.

Here’s the PJET one-year chart…

PJET spiked 190% on the new filings news, hitting a 52-week high. I traded the late day run. It was stuffing right near the early afternoon highs so I cut for a small win. See my PJET trades here.*

(*These kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products.  From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. This figure is taken from tracking user accounts on, a trading community platform. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.)

Top Penny Stocks List Weekly Update #2: Global Tech Industries Group Inc. (OTCQB: GTII)

Global Tech Industries Group currently has no operations. It claims ownership of intellectual property in the bioscience, green-tech and health sectors.

On Friday, the company announced purchase of an original Picasso etched engraving. Its goal is to create a digital art platform that pays ‘tokenized valued dividends’ to shareholders

CEO David Reichman said, “We believe that our vision of a digitized platform for fine art and collectibles, and the benefits it offers to our shareholders, far outweighs any challenges associated with actualizing this opportunity in the very near future. We are at work on this now 24/7, and the clock is ticking. Having purchased the Picasso, we demonstrated to our shareholders and to all our other constituents that GTII is committed and on the move.”

Read the full press release here.

Check out the GTII one-year chart…

GTII spiked on the news but then pulled back sharply. It finished the day up roughly 5%. I traded GTII on Friday, taking a small loss when there was no follow-up spike. See my GTII trades here.*

I’ll keep watching GTII, ideally for potential dip buys.

Top Penny Stocks List Weekly Update #3: Champignon Brands Inc. (OTCPK: SHRMF)

Champignon Brands formulates and sells psychedelic mushroom-infused beverages.

SHRMF had two catalysts on Friday…

First, the British Columbia Securities Commission and Ontario Securities Commission revoked cease trade orders. The cease trade orders applied to the company’s Canadian ticker — SHRM.

CEO Dr. Roger McIntyre said, “We are pleased to be moving forward with a strengthened team and focus on governance. We have successfully advanced our business strategy to establish a network of clinics designed to provide rapid-acting treatments for adults with depression.

“Depression is known to be one of the most disabling conditions across Canada and around the world. In addition, we have also been able to advance our research and development towards discovering novel drug treatments for individuals affected by depression.”

Read the full press release here.

SHRMF also got a boost as a sympathy to MMEDF, the next stock on this week’s watchlist.

Here’s the SHRMF one-year chart…

SHRMF spiked 97% in the first hour of trading Friday before pulling back. It consolidated the rest of the day, held most of its gains, and closed up 75%.

It’s tough for me to chase stocks up so much in this slower market. Also, even though I sometimes trade foreign tickers, they’re not my favorite. (An ‘F’ at the end of a ticker designates a foreign company trading on a U.S. market.)

See my SHRMF trades here.* I’ll keep watching, ideally for a potential dip buy. Also, I’ll watch SHRMF as a potential sympathy play to the next stock on this week’s watchlist…

Top Penny Stocks List Weekly Update #4: Mind Medicine Inc (OTCQB: MMEDF) or (NASDAQ: MNMD) from April 27.

Mind Medicine Inc. is a psychedelic medicine biotech. It focuses on using psychedelics, including mushrooms and LSD, to treat mental illness.

MMEDF spiked on news of uplisting to the Nasdaq exchange. Trading will commence on April 27 under the ticker MNMD.

CEO J.R. Rahn said, “The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly traded company. We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value.

“I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”

Read the full press release here.

Here’s the MMEDF one-year chart…

MMEDF spiked 65% Friday on the uplisting news. It closed strong, very near the day’s high.

I’m watching MMEDF for potential dip buys, ideally near the market open. I’ll also watch closely to see what happens on April 27 when the stock starts trading on the Nasdaq. See my MMEDF trades here.*

download penny stocks checklist free

Top Listed Penny Stocks to Watch

Here are my listed penny stocks to watch for the week of April 26, 2021. These higher priced plays are worth watching for potential dip buys, ideally at the market open.

Top Penny Stocks List Weekly Update #5: Ocugen, Inc. (NASDAQ: OCGN)

Ocugen is a clinical-stage biopharma focused on therapies for eye diseases. Ocugen is working with India-based partner company Bharat Biotech on a coronavirus vaccine called COVAXIN.

OCGN spiked 46% on April 21 after the company filed an 8-K announcing Phase 3 clinical trial results for COVAXIN.

CEO Dr. Shankar Musunuri said, “We continue to be excited by the compelling second interim results of Bharat Biotech’s Phase 3 clinical trial. We believe that COVAXIN can help change the course of this pandemic by preventing severe COVID-19 disease including hospitalizations by 100% as well as significantly limit the spread of asymptomatic COVID-19 infections based on efficacy shown to date.”

Read the full press release here.

Check out the OCGN one-year chart…

OCGN spiked another 46% on Friday. But it gave up the gains when the company announced a $100 million direct offering.

I’ll watch OCGN for potential dip buys into any big morning panics. See my OCGN trades here.*

That’s it for this week’s top penny stocks list. Want to know how to create your own watchlist?

How to Create Your Own Penny Stock List

penny stocks list

© document.write(new Date().getFullYear()); Millionaire Media, LLC

How Can You Create Your Own Watchlist?

To start, look for big percent gainers. For two decades, big percent gains have been my #1 criteria. After that, I look at trading volume and a catalyst or reason behind the price action. Read “Stock Watchlist Guide: Tips & Examples to Develop Your Own” for details about the entire process.

Should I Create a Watchlist Every Day?

All serious traders create a daily watchlist. If you’re serious about trading penny stocks, making a daily watchlist is essential.

Does Tim Sykes Provide a NO-COST Watchlist?

Yes. Subscribe to my weekly penny stock watchlists below.

How to Use the Top Penny Stocks List Weekly Update

When you read the weekly penny stock list (and the monthly watchlist), don’t think of them as hot picks. Frankly, sometimes they’ll be duds. That’s why it’s called a watchlist. Welcome to penny stocks.

👉🏼SUBSCRIBE to my NO-COST weekly stock watchlist here.

Instead, try to figure out why I’ve put the stocks on my list. Study so you can help yourself become a self-sufficient trader. Only fools chase hot picks.

What do you think about this penny stocks list weekly update? Comment below, I love to hear from all my readers! 

The post Top Penny Stocks List Weekly Update: April 26, 2021 appeared first on Timothy Sykes.